Last Updated: September 23, 2026

Basf Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for BASF

BASF has five approved drugs.



Summary for Basf
US Patents:0
Tradenames:2
Ingredients:1
NDAs:5

Drugs and US Patents for Basf

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Basf IBU ibuprofen TABLET;ORAL 018197-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial
Basf IBU ibuprofen TABLET;ORAL 070745-001 Jul 23, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial
Basf RUFEN ibuprofen TABLET;ORAL 018197-002 Mar 5, 1984 DISCN No No ⤷  Start Trial ⤷  Start Trial
Basf IBU ibuprofen TABLET;ORAL 070083-001 Feb 22, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial
Basf IBU ibuprofen TABLET;ORAL 070099-001 Mar 29, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial
Basf IBU ibuprofen TABLET;ORAL 070088-001 Feb 8, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.